Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
MGC Acquires QualCare Alliance Networks Inc.
Mitchell | Genex | Coventry completes the acquisition of QualCare Alliance Networks Inc. demonstrating the company's commitment to network expansion.
The PAID Act is Coming to Medicare—Are You Ready?
In December 2020, an act was signed into law, which will change the way some reporting entities coordinate Medicare benefits. This PAID Act will go into effect before year's end, but CMS is busy preparing for the change. In today’s podcast, Deborah Robinson-Stewart, joins us to explain.
Workers’ comp networks are constantly evolving
Amid all the changes in health care — and all the challenges that remain — experienced workers’ comp networks are evolving to meet the needs of providers, injured workers, and employers.
Mitchell | Genex | Coventry completes the Acquisition of QualCare Alliance Networks Inc.
Mitchell | Genex | Coventry Completes Acquisition of QualCare Alliance Networks Inc.
Deal demonstrates company's commitment to network expansion San Di
Michigan No-Fault Auto Fee Schedule Frequently Asked Questions
On July 2, 2021, the new Michigan fee schedule goes into effect for services rendered on or after that date. As we approach the effective date, there are details of the fee schedule that are still unclear.